Drugs / BI 113608
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT01958008 | Sep 2013 → May 2014 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01922349 | Aug 2013 → May 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01787032 | Jan → Apr 2013 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01681277 | Sep 2012 → May 2013 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01540825 | Feb → May 2012 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01703858 Comparator | Sep 2012 → Jan 2013 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 113608 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01958008 ↗ |
| Known as | BI 113608 PIB | “Drug: BI 113608 PIB” NCT01703858 ↗ |
| Route | Oral | “following oral administration of single rising doses” NCT01540825 ↗ |